Wednesday, July 5th
  • About Us
  • Copyright
  • Disclaimer
  • Privacy Policy
  • Terms&Conditions
  • Contact Us
    • Advertisement
  • Site Map
Biosimilar News
  • Twitter
  • RSS
  • News/Headlines
  • Events
    • Upcoming Events
    • Past Events
  • Guidelines
  • Policies
  • Research/Analysis
USEFUL TIP: In order not to miss any updates, follow us on Twitter or sign up for our Newsletter..

Follow Us

  • Subscribe by RSS Subscribe by RSS
  • Contact us via E-Mail
  • Follow us on Twitter
  • Follow us on LinkedIn
 

Sign up for our newsletter

All-time Popular Posts

  • A biobetter trastuzumab is on the way A biobetter trastuzumab is on the way
  • EGA president calls on Member States to boost market access for biosimilars in the EU EGA president calls on Member States to boost market access for biosimilars in the EU
  • 3rd Forum on Biosimilars 3rd Forum on Biosimilars
  • Pfizer starts biosimilar rituximab Phase I/II trial Pfizer starts biosimilar rituximab Phase I/II trial
  • Indian Biosimilars Market Indian Biosimilars Market
  • World’s first biosimilar antibody* is approved in Korea World’s first biosimilar antibody* is approved in Korea
  • A biosimilar manufacturer: Celltrion A biosimilar manufacturer: Celltrion
  • 2 patents down, 1 to expire: Herceptin biosimilar coming to EU 2 patents down, 1 to expire: Herceptin biosimilar coming to EU

Archives

Twitter Updates

Archive for January, 2014

January 31, 2014 12:48 PM

Roche against biosimilars: MabThera SC now approved in EU

January 24, 2014 10:24 AM

CHMP adopts positive opinion for Bemfola for infertility

January 17, 2014 2:01 PM

12th EGA International Biosimilar Medicines Conference

January 17, 2014 1:37 PM

Celltrion’s Herzuma (trastuzumab) now approved in S.Korea

January 14, 2014 10:29 AM

9th Annual Summit on Biosimilars

January 14, 2014 10:02 AM

J & J petition to FDA regarding naming of biosimilars

January 9, 2014 11:47 AM

Epirus – Ranbaxy agreement for infliximab biosimilar in India & SEA

© Copyright 2017 — Biosimilar News. All Rights Reserved Powered by Wordpress